NCT06369181View on ClinicalTrials.gov

Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC

RecruitingOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions

Neuroendocrine CarcinomaNon-small Cell Lung CancerHistology Transformation

Trial Locations (1)

200032

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER